(Reuters) -GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward. If Judge Vivian Medinilla of Delaware Superior Court grants the petition, which is also joined by Pfizer, Sanofi and Boehringer Ingelheim, the appeal will go directly to the Delaware Supreme Court. If she denies it, GSK said, the companies will ask the Supreme Court directly to hear the case.
Latest trial over Zantac cancer claims called off | Honolulu Star-Advertiser staradvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from staradvertiser.com Daily Mail and Mail on Sunday newspapers.
Major pharmaceutical companies, including GSK, Pfizer, Sanofi, and Boehringer Ingelheim, are seeking permission from a Delaware court to appeal a ruling that allows over 70,000 lawsuits claiming that the heartburn drug Zantac causes cancer to proceed. The companies argue against the admissibility of expert testimony linking Zantac to cancer.
A woman who claimed in a lawsuit
that GSK s discontinued heartburn drug Zantac caused her
breast cancer dropped her case shortly before it was set to go
to trial in Illinois state court on Monday, the.
Latest trial over Zantac cancer claims called off as plaintiff drops case yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.